Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2

Urological Research

Volumn 30, Issue 4, 2002, Pages 240-247

  Bindels, E M J ^a   Van der Kwast, T H ^a   Izadifar, V ^b   Chopin, D K ^b   De Boer, W I ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Bladder; EGF like growth factors; ErbB receptor; Oligonucleotides; Reepithelialization

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; PROTEIN PS2;

ARTICLE; CANCER INVASION; CATHETERIZATION; CELL MIGRATION; CELL PROLIFERATION; EPITHELIZATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN FAMILY; TARGET CELL; TUMOR GROWTH; UROTHELIUM; VIRUS GENE; WOUND CLOSURE; WOUND HEALING;

CELLS, CULTURED; DNA, ANTISENSE; EPIDERMAL GROWTH FACTOR; HUMANS; RECEPTOR, ERBB-2; REGENERATION; URETER; UROTHELIUM;

EID: 0036919920     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-002-0260-7     Document Type: Article

References (37)

1. Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH (1997) Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J 16: 5608
2. Alroy I, Yarden Y (1997) The erbB signalling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410: 83
3. Ben-Levy R, Paterson HF, Marshall CJ, Yarden Y (1994) A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J 13: 3302
4. Benz CC, O'Hagen RC, Richter B, Scott GK, Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A, Hassell JA (1997). Her2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15: 1513
5. Bernstein JJ, Goldberg WJ, Laws ER (1993) Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro. J Neurooncol 18: 151
6. Bindels EMJ, Vermey M, Rebel JMJ, Zwarthoff EC, van der Kwast TH (1997) In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor. Exp Cell Res 235: 355
7. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ, Holtzin GS, Schultz GS, Jurkiewicz MJ, Lynch JB (1989) Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 321: 76
8. Carraway KL, Cantley LC (1994) A Neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signalling. Cell 78: 5
9. Cilento BG, Freeman MR, Schneck FX, Retik AB, Atala A (1994) Phenotypic and cytogenetic characterization of human bladder expanded in vitro. J Urol 152: 665
10. Daher A, El-Marjou A, de Boer WI, Abbou CC, Thiery J-P, van der Kwast T, Radvanyi F, Chopin D (1999) Functional effect of epidermal growth factor receptor in urothelial regeneration. Eur Urol 35 (Suppl 2): a321
11. Dangles V, Femenia F, Laine V, Berthelemy M, Le Rhun D, Poupon MF, Levy D, Schwartz-Cornil I (1997) Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines. Cancer Res 57: 3360
12. Danilenko DM, Ring BD, Lu JZ, Tarpley JE, Chang D, Liu N, Wen D, Pierce GF (1995) Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. J Clin Invest 95: 842
13. Davies BR, Auersperg N, Worsley SD, Ponder BAJ (1998) Transfection of rat ovarian surface epithelium with erbB2/neu induces transformed phenotypes in vitro and the tumorigenic phenotype in vivo. Am J Pathol 152: 297
14. De Boer WI, Schuller AGP, Vermey M, van der Kwast TH (1994) Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol 145: 1199
15. De Boer WI, Rebel JMJ, Vermey M, de Jong AAW, van der Kwast TH (1994) Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic cultures. Exp Cell Res 214: 510
16. De Boer WI, Vermey M, Gil Diez S, Bindels E, Radvanyi F, van der Kwast T, Chopin D (1996) Functions of fibroblast and transforming growth factors in primary organoid-like cultures of normal human urothelium. Lab Invest 75: 147
17. De Boer WI, Houtsmuller AB, Izadifar V, Muscatelli-Groux B, van der Kwast T, Chopin DK (1997) Expression and functions of EGF, FGF and TGFβ-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells. Int J Cancer 71: 284
18. De Corte V, De Potter C, Vandenberghe D, van Laerebeke N, Azam M, Roels H, Mareel M, Vanderkerckhove J (1994) A 50-kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility and activates tyrosine phosphorylation of neu/HER-2 in human SK-BR-3 mammary cancer cells. J Cell Sci 107: 405
19. D'Souza B, Taylor-Papadimitrou J (1994) Overexpression of the erbB2 gene in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci U S A 15: 7202
20. Dubeau L, Jones PA (1987) Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res. 47: 2107
21. Gibson S, Tu S, Oyer R, Anderson SM, Johnson GL (1999) Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation. J Cell Biol 274: 17612
22. Heldin C-H (1995) Dimerization of cell surface receptors in signal transduction. Cell 80: 213
23. Imai T, Kimura M, Takeda M, Tomita Y (1995) Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumor recurrence at the urinary bladder. Br J Cancer 71: 69
24. Jost SP (1989) Cell cycle of normal bladder urothelium in developing and adult mice. Virchows Archiv B Cell Pathol 57: 27
25. Kimball ES, Bohn WH, Cockley KD, Warren TC, Sherwin SA (1984) Distinct high-performance-liquid-chromatography pattern of transforming-growth-factor activity in urine of cancer patients as compared with that of normal individuals. Cancer Res 44: 3616
26. Messing EM, Hanson P, Ulrich P, Erturk E (1987) Epidermal growth factor-interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 138: 1329
27. Messing EM, Reznikoff CA (1987) Normal and malignant human urothelium: in vitro effects of epidermal growth factor. Cancer Res 47: 2230
28. Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y (1998) The oncogenic erbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and beta-cellulin. Oncogene 16: 1249
29. Podolski DK (1997) Healing the epithelium: solving the problem from two sides. J Gastroenterol 32: 122
30. Rajkumar T, Stamp GWH, Pandha HS, Waxman J, Gullick WJ (1996) Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer. J Pathol 179: 381
31. Rebel JMJ, De Boer WI, Thijssen CDEM, Vermey M, Zwarthoff EC, van der Kwast TH (1994) An in vitro model of urothelial regeneration: effects of growth factors and extracellular matrix proteins. J Pathol 175: 283
32. Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twardzik DR, Todaro GJ (1987) Epithelial wound healing enhanced by transforming growth factor-α and vaccinia growth factor. Science 235: 350
33. Southgate J, Hutton KAR, Thomas DFM, Trejdosiewicz LK (1994) Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 71: 583
34. Thompson JS (1999) Epidermal growth factor inhibits somatostatin-induced apoptosis. J Surg Res 81: 95
35. Vaughn JP, Iglehart JD, Demirdji S, Davis P, Babiss LE, Caruthers MH, Marks JR (1995) Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay. Proc Natl Acad Sci U S A 92: 8338
36. Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T, Rijksen G (1998) Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human cancer cells and NIH3T3 fibroblasts. FEBS Lett 425: 145
37. Vinter-Jensen L, Juhl CO, Djurhuus JC, Poulsen SS, Dajani EZ, Brown KD, Ørntoft TF, Teglbjaerg PS, Nexø E (1995) Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol 147: 1330